GlassScriptPhysician profile
Marc Radabaugh
NPI 1104358670
$660.06
in general payments reported to CMS, 2019-2025
16 companies · $259 in 2025
The $259 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $57.26 · 2022: $66.94 · 2023: $146 · 2024: $131 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $535.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $126.13 | 2021-2025 | |
| Lilly USA, LLC | $95.95 | 2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $93.45 | 2022-2025 | Ozempic, Rybelsus |
| Abbott Laboratories | $86.81 | 2023-2024 | Freestyle Libre 3 |
| Amgen INC. | $45.83 | 2025 | Repatha, Otezla, Evenity |
| Glaxosmithkline, LLC. | $45.59 | 2024-2025 | Shingrix, Arexvy, Bexsero |
| Intuity Medical INC | $27.78 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Novartis Pharmaceuticals Corporation | $20.78 | 2023 | |
| Phathom Pharmaceuticals, INC. | $18.64 | 2025 | Voquezna |
| Grifols USA, LLC | $18.64 | 2025 | Prolastin-C Liquid |
| Abbvie INC. | $16.08 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.07 | 2023 | Seglentis |
| Bayer Healthcare Pharmaceuticals INC. | $13.61 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $13.58 | 2025 | Farxiga |
| Amarin Pharma, INC. | $11.87 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Radabaugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.